BofA Securities slashes price target on VEON Ltd. [VEON] – find out why.


VEON Ltd. [NASDAQ: VEON] closed the trading session at $0.63 on 05/03/22. The day’s price range saw the stock hit a low of $0.611, while the highest price level was $0.653. The company report on April 29, 2022 that VEON files Form 20-F for financial year 2021.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .


VEON Ltd. (NASDAQ: VEON) (Euronext Amsterdam: VEON), a leading global provider of connectivity and digital services, today announces that it has filed its Annual Report on Form 20-F for the year ended 31 December 2021 (the “Form 20-F”) with the U.S. Securities and Exchange Commission at The Form 20-F is also available on the Investor Relations section of the company’s website

Shareholders may request a hard copy of the Form 20-F, including VEON’s complete audited financial statements for the year ended 31 December 2021, free of charge, by contacting VEON’s Investor Relations Department at

The stocks have a year to date performance of -63.09 percent and weekly performance of 5.20 percent. The stock has been moved at -70.23 percent over the last six months. The stock has performed -14.01 percent around the most recent 30 days and changed -55.56 percent over the most recent 3-months.

If compared to the average trading volume of 34.67M shares, VEON reached to a volume of 7441889 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here’s what leading stock market gurus have to say about VEON Ltd. [VEON]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for VEON shares is $2.87 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on VEON stock is a recommendation set at 2.10. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

BofA Securities have made an estimate for VEON Ltd. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on August 26, 2021. The new note on the price target was released on January 27, 2021, representing the official price target for VEON Ltd. stock.

The Average True Range (ATR) for VEON Ltd. is set at 0.04, with the Price to Sales ratio for VEON stock in the period of the last 12 months amounting to 0.14. The Price to Book ratio for the last quarter was 2.87, with the Price to Cash per share for the same quarter was set at 0.86. Price to Free Cash Flow for VEON in the course of the last twelve months was 1.60 with Quick ratio for the last quarter at 0.60.

VEON stock trade performance evaluation

VEON Ltd. [VEON] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 5.20. With this latest performance, VEON shares dropped by -14.01% in over the last four-week period, additionally sinking by -70.23% over the last 6 months – not to mention a drop of -64.94% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for VEON stock in for the last two-week period is set at 50.39, with the RSI for the last a single of trading hit 54.24, and the three-weeks RSI is set at 46.43 for VEON Ltd. [VEON]. The present Moving Average for the last 50 days of trading for this stock 0.5940, while it was recorded at 0.6391 for the last single week of trading, and 1.5293 for the last 200 days.

VEON Ltd. [VEON]: An insightful look at the core fundamentals

Operating Margin for any stock indicates how profitable investing would be, and VEON Ltd. [VEON] shares currently have an operating margin of +19.83. VEON Ltd.’s Net Margin is presently recorded at +6.73.

Return on Total Capital for VEON is now 13.91, given the latest momentum, and Return on Invested Capital for the company is 4.99. Return on Equity for this stock inclined to 60.87, with Return on Assets sitting at 3.42. When it comes to the capital structure of this company, VEON Ltd. [VEON] has a Total Debt to Total Equity ratio set at 688.37. Additionally, VEON Total Debt to Total Capital is recorded at 87.32, with Total Debt to Total Assets ending up at 65.07. Long-Term Debt to Equity for the company is recorded at 688.37, with the Long-Term Debt to Total Capital now at 87.32.

VEON Ltd.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.60 and a Current Ratio set at 0.60.

VEON Ltd. [VEON]: Insider Ownership positions

There are presently around $304 million, or 27.80% of VEON stock, in the hands of institutional investors. The top three institutional holders of VEON stocks are: EXOR CAPITAL LLP with ownership of 106,431,775, which is approximately 35.846% of the company’s market cap and around 39.60% of the total institutional ownership; MORGAN STANLEY, holding 50,244,644 shares of the stock with an approximate value of $32.26 million in VEON stocks shares; and SHAH CAPITAL MANAGEMENT, currently with $32.23 million in VEON stock with ownership of nearly 154.709% of the company’s market capitalization.

71 institutional holders increased their position in VEON Ltd. [NASDAQ:VEON] by around 96,228,710 shares. Additionally, 54 investors decreased positions by around 35,571,106 shares, while 18 investors held positions by with 341,884,770 shares. The mentioned changes placed institutional holdings at 473,684,586 shares, according to the latest SEC report filing. VEON stock had 20 new institutional investments in for a total of 11,224,088 shares, while 16 institutional investors sold positions of 1,549,666 shares during the same period.